Results 241 to 250 of about 12,260,572 (400)

Current and novel biomarkers in cardiogenic shock

open access: yesEuropean Journal of Heart Failure, EarlyView.
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.
Victor Galusko   +5 more
wiley   +1 more source

Identifying the culprit artery via 12‐lead electrocardiogram in inferior wall ST‐segment elevation myocardial infarction: A meta‐analysis

open access: yesAnnals of Noninvasive Electrocardiology, Volume 28, Issue 1, January 2023., 2023
Sometimes the easiest way is the best. Simple methods as ST‐segment elevation in III > II and ST‐segment depression in aVL > I are effective diagnostic test for identifying culprit artery in inferior wall ST‐segment elevation myocardial infarction. Complex algorithms are not superior to simple methods.
Peng Zhou   +9 more
wiley   +1 more source

Troponin‐T: improved diagnostic assessment of myocardial damage in childhood [PDF]

open access: bronze, 1997
FF Immer   +5 more
openalex   +1 more source

End‐organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure‐2 (RELAX‐AHF‐2)

open access: yesEuropean Journal of Heart Failure, EarlyView.
End‐organ protective effect of serelaxin in patients with acute heart failure. CV, cardiovascular; HF, heart failure; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Abstract Aims Serelaxin is recombinant human relaxin‐2, a hormone responsible for haemodynamic adaptations and organ protection in pregnancy.
Adriaan A. Voors   +12 more
wiley   +1 more source

Skeletal muscle and subcutaneous fat quantity as prognostic indicators in cardiac amyloidosis

open access: yesEuropean Journal of Heart Failure, EarlyView.
Aims Disease‐related changes in body composition are associated with worse outcomes in chronic heart failure. In cardiac amyloidosis (CA), the prognostic value of direct body composition measures is understudied. Methods and results We identified 160 consecutive patients with CA (transthyretin [ATTR] or light chain [AL]) diagnosed between 2001 and 2021
Joshua Longinow   +4 more
wiley   +1 more source

Cardiac troponin T and I: back to basics. [PDF]

open access: yesEur Heart J Acute Cardiovasc Care, 2023
Mingels AM, Mills NL, Mueller C.
europepmc   +1 more source

The use of left ventricular ejection fraction in the diagnosis and management of heart failure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS)

open access: yesEuropean Journal of Heart Failure, EarlyView.
Abstract This clinical consensus statement revisits the role of left ventricular ejection fraction (LVEF) as a measurement of cardiac function, a prognostic marker and a major criterion to classify patients with heart failure, and gives new advice for clinical practice.
Giuseppe M.C. Rosano   +20 more
wiley   +1 more source

Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction [PDF]

open access: bronze, 1999
E. Magnus Ohman   +10 more
openalex   +1 more source

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease

open access: yesCirculation, 2017
V. Baggen   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy